Home
Sandu Pharmaceuticals Ltd Share Price History
Sandu Pharmaceuticals Ltd
BSE : 17 Apr, 2025
50.882.4 (4.9%)
Prev Close
48.5
Open Price
48.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
40400
Today's High / Low
54.5 / 48.3
52 WK High / Low
69.5 / 43.8
Market Price of Sandu Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 1.57 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 40.62 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 5.86 |
| Op. Profit Mgn % | 4.3 |
| Net Profit Mgn % | 2.33 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Sandu Pharmaceuticals Ltd
- Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
- The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
- This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
- Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
- Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
Popular Search
FAQs for Sandu Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Sandu Pharmaceuticals Ltd's share price history?
Key events that impact Sandu Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Sandu Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Sandu Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Sandu Pharmaceuticals Ltd?
Dividends can influence Sandu Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Sandu Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Sandu Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Sandu Pharmaceuticals Ltd’s share price history?
To understand Sandu Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
